Key facts
- It has raised $175.0M; the latest was PE Growth/Expansion ($175.0M) in Aug 2025.
- Notable investors include Advent International.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Felix Pharmaceuticals (Dublin)
- ·The full record, as it builds
Funding rounds
No funding rounds for Felix Pharmaceuticals (Dublin) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Felix Pharmaceuticals (Dublin)
Manufacturer of generic medicines intended for veterinary care. The company manufactures plain tablets, chewable, soft chewable, oral liquids, and oral pastes, thereby enabling access to cost-effective, high-quality bio-equivalent products tailored for companion pets.
- Sector
- Healthcare
- HQ
- Dublin, Ireland
- Founded
- 2015
- Employees
- 500
- Website
- felixvet.com/
- Ownership
- Privately Held (backing)
Felix Pharmaceuticals (Dublin) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Felix Pharmaceuticals (Dublin) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Felix Pharmaceuticals (Dublin) in its N-PORT filings yet. We sweep new filings monthly.